Biogen (BIIB) Tops Q1 EPS by $1.40
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $199.71 --0%
Revenue Growth %: -6.5%
Financial Fact:
Net income: 1.03B
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -6.5%
Financial Fact:
Net income: 1.03B
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $9.14, $1.40 better than the analyst estimate of $7.74. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.41 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M
- Bristow Group to acquire Berry Aviation for $105 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
